Stevens-Johnson Syndrome (SJS) is a rare but serious disorder that affects the skin and mucous membranes. It is characterized by a severe and potentially life-threatening reaction, often triggered by certain medications or infections. The prevalence of SJS varies across different populations and regions.
While it is challenging to provide an exact prevalence rate, studies suggest that the incidence of SJS is estimated to be around 1 to 6 cases per million people per year. However, the prevalence may be higher in certain ethnic groups, such as individuals of Asian descent, where rates of up to 10 cases per million people per year have been reported.
It is important to note that SJS is considered a rare condition, but its potential severity and impact on individuals make it a significant concern in healthcare. Prompt recognition, early intervention, and avoidance of known triggers are crucial in managing this condition and minimizing its complications.